press release
AI and Drosophila-Based Biomanufacturing for Protein Design and Production: Future Fields and Protein Evolution Form Partnership
Future Fields joins 11 other partners in Protein Evolution’s Partner Alliance Program
Creators of the world-first Drosophila-based EntoEngine expression system and the world’s fastest polyester-degrading enzyme partner to tackle gaps in protein production
EDMONTON, Alberta (MAY 15, 2025) – Future Fields, a biomanufacturing company leveraging Drosophila melanogaster to produce difficult-to-express proteins at scale, today announces its partnership with Protein Evolution, an AI-powered protein discovery and engineering platform dedicated to accelerating the creation of high-performing molecules. Combining world-firsts in computational excellence and novel protein expression, this partnership aims to expedite the production of crucial proteins for the next generation of medicine, agricultural solutions, and beyond.
“This partnership is about more than just accelerating protein production—it’s about reshaping what’s possible to improve life on earth,” says Matt Anderson-Baron, co-founder and CEO of Future Fields. “By uniting Protein Evolution’s AI-powered design capabilities with our unique ability to express complex proteins at scale, we’re building a faster, more responsive biomanufacturing ecosystem for the world.”
Future Fields and Protein Evolution’s partnership announcement is in tandem with the public launch of the Partner Alliance Program - a global network of 12 specialized laboratory partners offering expertise in discovery, testing, validation, and scale-up, strengthened by Protein Evolution’s AI-powered protein engineering workflows. Together, this alliance serves to close gaps in protein production by accelerating design-to-clinic cycles and offering true end-to-end solutions to life sciences changemakers.
Alliance partners include:
-
BioDesign Innovations
-
Boster Bio
-
Creative BioLabs
-
Creative Enzymes
-
Helix Biostructures
-
Ichor Life Sciences
-
Olympic Protein Technologies
-
Neochromosome
-
Ray Biotech
-
SeSam Biotech
"We’re excited to launch our Partner Alliance and proud to welcome Future Fields as a founding partner,” says Alex Gerson, Head of Operations at Protein Evolution. “Collaborating with innovative companies like Future Fields enables us to bridge the gap between AI-driven design and experimental validation, advancing the field of protein engineering. With Future Fields’ unique capabilities, we can accelerate our iterative processes and deliver superior outcomes for our clients, allowing them to tackle the greatest challenges in healthcare, sustainability, and beyond."
In other news
Future Fields Debuts Instar 1.0: A Biofactory With 30 Times the Output of Conventional Protein Technology
11/13/2024
Future Fields looks to solve industry's biomanufacturing woes with fruit fly-based protein production
11/12/2024
About Future Fields
Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science.
As of 2023, our lab has been Green-certified by My Green Lab, and our FGF2 are the first growth factors in the world to receive the ACT Environmental Impact Factor Label. Future Fields is a proud business member of 1% for the Planet and the United Nations Global Compact initiative.
Learn more about how we’re transforming science at futurefields.io.